A murine polyclonal antiserum and monoclonal antibodies have been employed to identify pneumonia virus of mice (PVM) polypeptides in infected cells and to study post-translational modifications. Immunoprecipitation experiments using a murine polyclonal antiserum and a monoclonal antibody directed against a 39K protein have established an antigenic relationship between two PVM proteins and the N and P proteins of human respiratory syncytial virus. Although 20 virus-specific polypeptides have been identified in lysates of infected cells, evidence is presented that some of these are related and that the number of unique polypeptides probably does not exceed 11 or 12. The phosphoproteins of PVM have a pattern of mobilities more like that of the recently described pneumovirus causing rhinotracheitis in turkeys than that of human or bovine respiratory syncytial virus.
INTRODUCTION
Pneumonia virus of mice (PVM) has been classified as a member of the genus Pneumovirus of the family Paramyxoviridae along with the human and bovine respiratory syncytial (RS) viruses, largely on the basis of morphology (Kingsbury et al., 1978) . Recently it has been proposed that turkey rhinotracheitis (TRT) virus should be classified in this genus (Barrett & Cavanagh, 1988; Collins & Gough, 1988; Ling & Pringle, 1988) , All of these viruses have similar morphological features and the major unglycosylated potypeptides have similar, although not identical, mobilities when analysed by SDS-PAGE. Polypeptides of PVM have been described previously (Cash et al., 1977 (Cash et al., , 1979a . However, since PVM infection does not shut off host cell protein synthesis and immunological detection of the polypeptides was not used, poorly labelled viral polypeptides of low abundance would have escaped detection. One instance of serological crossreaction between PVM and human RS virus has been described; a hyperimmune murine anti-RS virus serum reacted with the PVM N protein in Western blot analysis (Gimenez et al., 1984) .
The polypeptides of PVM show some similarity to those of RS virus, in their pattern of electrophoretic mobilities, but there are also several differences particularly with respect to the glycoproteins. In the present study monoclonal antibodies (MAbs) and a hyperimmune mouse serum have been used to characterize the PVM polypeptides further.
METHODS
Cells. BS-C-1 cells were grown in roller bottles in the Glasgow modification of Eagle's medium supplemented with non-essential amino acids (GMEM) and 5~ foetal bovine serum (FBS). The cells were split 1 to 4 at 4-day intervals. 3T12-3 BALB/c cells were passaged in flat bottles in a similar manner. Hybridoma cells and X63-Ag8-653 cells (obtained from Flow Laboratories) were subcultured by 10-fold dilution in RPMI 1640 medium supplemented with 10~ FBS at 3-day intervals. For the growth of hybridoma cells ESG hybridoma growth factor (Northumbria Biologicals), hypoxanthine (10-* M) and thymidine (1.6 x 10 -5 M) were included in the RPMI 1640 medium.
Viruses. PVM, strain 15, was obtained originally from the American Type Culture Collection and had been cloned as described previously (Cash et aL, 1979a) . The RSS-2 strain of human RS virus (Cash et al., 1977) was 0000-8647 © 1989 SGM used and the TRT virus was a focal plaque variant of virus originally obtained from Dr R. E. Gough of the Central Veterinary Laboratory, Weybridge, Surrey, U.K., propagated as described previously (Ling & Pringle, 1988) . The viruses were all passaged three times in BS-C-1 cells following initial growth from a single plaque. The virus obtained from one flask was used to infect five further flasks at each passage. After a 2 h adsorption period the inoculum was replaced by GMEM containing 1 ~ FBS and virus was harvested by scraping the cells into the medium and used to infect more BS-C-1 cells. The virus-infected cells were incubated at 33 °C for 3 days before harvesting. After the final passage, the harvested virus was stored at -70 °C.
Production of immunogens for immunization of mice. 3T12-3 BALB/c cells were infected with PVM at an m.o.i, of 4 and incubated at 31 °C for 15 days. The cells were harvested by scraping them into medium and freezing after three washes in phosphate-buffered saline (PBS). PVM was partially purified from the supernatant of infected BS-C-1 cells using a flotation gradient as has been described for the purification of RS virus (Fernie & Gerin, 1980) .
Immunization of mice and production ofMAbs. PVM-specific MAbs were obtained from two fusion experiments (numbered 19 and 26). Six-week-old BALB/c mice were inoculated intraperitoneally with l07 PVM-infected 3T 12-3 BALB/c cells. In fusion experiment 19 two further injections of the same type were given at intervals of 2 weeks. In fusion experiment 26 one further injection of virus-infected cells was given after 2 weeks and after a further 3 weeks two final intravenous injections of partially purified virus were given (7 and 4 days before fusion). Four days after the final injection the spleens were removed and fused with X63-Ag8-653 myeloma cells according to the method of Galfr~ et al. (1977) . The sera of the mice were collected and pooled. The cells were incubated overnight in microtitre plates (four or five plates/spleen) and then an equal volume of hybridoma medium supplemented with double strength aminopterin was added. The supernatants of the hybridoma colonies were screened by ELISA and positive clones were recloned three times before amplification as ascitic tumours in mice. Culture supernatants were used for Western blots and ascitic fluid for immunoprecipitation experiments.
ELISA. BS-C-1 cells were grown in 60-well HLA plates and alternate rows were infected with clarified PVM preparations. After 4 days when c.p.e, was extensive but the cells remained attached to the plates, the monolayers were washed with PBS, fixed with 0.25~ glutaraldehyde for 15 min and washed three times in PBS. The plates were incubated for 60 min with 3~o bovine serum albumin (BSA) and washed three times with PBS containing 0-1 ~ Tween 20 before storage at -20 °C. All subsequent washes were performed in a similar way. Hybridoma supernatants or a 1000-fold dilution of serum from immunized mice were incubated with the monolayers for 3 h at 37 °C after thawing and flicking offthe PBS. The plates were washed and incubated for 2 h at 37 °C with a 1/1000 dilution of biotinylated rabbit anti-mouse antibody (Amersham) in PBS containing 0.1 ~ BSA. The plates were washed and incubated with a 1/1500 dilution of biotinylated horseradish peroxidase-streptavidin complex (Amersham) for 30 min at 37 °C. After five washes with PBS containing 0.1 ~ Tween 20 the plates were incubated with o-phenylenediamine (10 mg in 10 ml 0.1 M-citrate buffer at pH 5 containing 8 ttl hydrogen peroxide).
Neutralization assay. Serial twofold dilutions of antibody were made in GMEM containing 0.59/00 foetal calf serum. An equal volume of diluted PVM containing 200 p.f.u, in 0.2 ml was added to each serum dilution and the mixtures were incubated overnight at 4 °C. A quantity (0-2 ml) of each mixture was added to duplicate monolayers of BS-C-1 cells in 12-well tissue culture clusters. After a 1 h adsorption period 3 ml of a 0.9~ agar-containing overlay was added and once it had set the plates were incubated at 37 °C for 7 days. The monolayers were fixed with 1 ~ glutaraldehyde in PBS and, following removal of the agar, stained with crystal violet. The neutralization titre was taken as the dilution of antibody causing a 50~ reduction in the number of plaques.
Radiolabelling of infected cells and immunoprecipitation of virus-specific polypeptides.
For radiolabelling of viral polypeptides monolayers of 106 BS-C-1 cells were infected with 8 x 106 p.f.u, of PVM or RS virus, and after adsorption for 2 h at 33 °C the inoculum was replaced with GMEM supplemented with l ~ FCS. Forty-eight h after inoculation this medium was replaced by methionione-free GMEM and the cells were incubated for 1 h at 33 °C before incubation for a further 24 h in the same medium plus 50 ~Ci/ml [35S]methionine. The cells were lysed on ice using 100 ~1 high salt RIP buffer (0.6 M-KCI, 0.1 mM-MgC12, 1 ~oo Triton X-100, 1 ~ sodium deoxycholate, 10 mM-Tris-HC1 pH 7.4) containing 1 mM-phenylmethylsulphonyl fluoride for 30 min. The lysate was clarified by centrifugation at 10000 g for 5 rain and 50 ~tl Immuno-Precipitin (Gibco-Bethesda Research Laboratories) in high salt RIP buffer and 5 gl ascitic fluid not showing any reaction with PVM polypeptides were added. The lysates were incubated for a further 30 min on ice, the Immuno-Precipitin was pelleted for 5 min at 10000 g and the supernatant was then incubated overnight with 40 gl of the appropriate antibody. Immuno-Precipitin in high salt RIP buffer (300 ~tl) was added and after 30 min on ice the precipitate was washed in 500 mM-LiCI, 100 mM-Tris-HC1 pH 8.5 by three cycles of resuspension and centrifugation at 10000 g for 1 min. The washed pellet was resuspended in 40 gl SDS lysis buffer (Laemmli, 1970) , boiled for 3 min, centrifuged for 1 min at 10000 g and the supernatant was loaded directly onto a gel or stored at -20 °C. Concentration of culture supernatants with polyethylene glycol (PEG) 6000 (final concentration 6~ w/v) was carried out as described by Cash et al. (1977) .
Immunoprecipitation of polypeptides in the concentrated supernatants was carried out in the same way as described above for cell lysates. Labelling of samples for analysis on two-dimensional gels was carried out in a similar way but the cells were grown in 96-well tissue culture plates and labelled with [3sS]methionine at 1 mCi/ml.
Labelling with 32p was carried out using a concentration of 500 laCi/ml. For pulse-chase experiments cells were labelled with [3sS]methionine at 400 0Ci/ml for 10 min, washed three times in cold GMEM containing 200 times the normal methionine concentration and then incubated in GMEM supplemented with 5 ~ FBS for various times at 33 °C.
Two-dimensional gel electrophoresis (NEPHGE). NEPHGE was carried out using pH 3.5 to 10 Ampholines (LKB) for 500 volt hours as described by O'Farrell et al. (1977) . The second dimension separation was carried out using 6 to 15~o gradient gels.
SDS-PAGE. Samples were analysed on gradient gels as described by Marsden et al. (1976) . Partial proteolysis of radiolabelled polypeptides. PVM polypeptides radiolabelled and immunoprecipitated with polyclonal serum as described above were excised from gels using the fluorograph as the template. The gel slices were rehydrated and digested during migration through a stacking gel as described by Cleveland et al. (1977) . Chymotrypsin at 1 mg/ml was used in the stacking gel buffer containing 10~ glycerol and bromophenol blue.
Western blot analysis. Proteins separated by SDS-PAGE were transferred to nitrocellulose using the Bio-Rad Trans-Blot apparatus as described by the manufacturer. Proteins were detected on blots using the biotinylated second antibody/biotinylated horseradish peroxidase-streptavidin system as described by the manufacturer (Amersham). The blots were incubated with the first antibody for 3 h and with the second antibody for 2 h. Horseradish peroxidase colour development reagent (Bio-Rad) was used as the substrate.
In vitro translations. Total cytoplasmic RNA was extracted from virus-infected cells and translated in vitro as previously described (Ling & Pringle, 1988) .
RESULTS

Analysis of pneumovirus polypeptides on two-dimensional gels
The PVM-and RS virus-specific polypeptides observed on two-dimensional gels of infected cell lysates are shown in Fig. 1 . The F1, N, P, M and M2 (22K) polypeptides of RS virus were observed along with polypeptides of estimated M~ 20K, 17K, 16K and 15K (Fig. 1 a) . The N, P, M, 17K, 16K and 15K polypeptides probably co~'respond to the 45K, 36K, 33K, 24K, 18K and 15K polypeptides described by Dubovi (1982) . One of the polypeptides with an Mr of 20K or below probably represents F2 while the others are the non-structural 1C and 1B polypeptides or breakdown products of larger polypeptides.
The PVM-specific polypeptides that were identified are shown in Fig. 1 (b) . These were the basic F0, F1 and M proteins, the two less basic 16K polypeptides and the acidic N, 39K, 35K, 25K, 20K, 19K and 18K polypeptides. The identification of F0 under reducing conditions was unexpected; in immunoprecipitates it was identified only under non-reducing conditions. The nomenclature for the PVM polypeptides uses the estimated MT of the polypeptides or, where appropriate, designations similar to those of RS virus polypeptides with similar mobilities, charge properties and post-translational modifications. The equivalent designations used by Cash et al. (1979a) are given in Table 1 .
P VM polypeptides synthesized in vitro
The PVM polypeptides synthesized in vitro have been described previously (Cash et al., 1979a; Ling & Pringle, 1988) . However, a different nomenclature was used and additional polypeptides have subsequently been identified so these polypeptides are briefly considered here. Fig. 2 shows PVM and RS virus polypeptides synthesized in vitro using a rabbit reticulocyte lysate system. The RS virus polypeptides observed are similar to those described by others (Cash et al., 1979b; Collins et al., 1984) , the 16K polypeptide being resolved on twodimensional gels into three spots, two of which probably correspond to the 1C and 1B polypeptides. The 12K polypeptide probably corresponds to the 1A polypeptide. RNA from PVM-infected cells gave a larger number of virus-specific polypeptides. Most of these corresponded to polypeptides identified in vivo although the intensities of the bands differed. The 16K polypeptide was resolved into two spots on two-dimensional gels similar to the two more acidic 16K polypeptides of RS virus (data not shown). A 48K polypeptide was identified that had not previously been described. 
Immunoprecipitation of RS virus N protein by anti-PVM serum
The results of immunoprecipitation of PVM, RS virus or mock-infected cell lysates and P E G precipitates of the supernatants of such cultures with murine anti-PVM serum or preimmune mouse serum are shown in Fig. 3 , The hyperimmune anti-PVM serum was collected from the mice used in the production of MAbs and had a neutralization titre of 1 : 45 000. The fluorograph is overexposed to show the PEG precipitate tracks. Some viral polypeptides could not always be identified in P E G precipitates due to low abundance and/or poor label incorporation. The murine anti-PVM serum immunoprecipitated the major PVM polypeptides and the RS virus N Cash et al. (1979a) .
t Polypeptides in infected cell lysates (in vivo) or in in vitro translation experiments. Two spots were observed on two-dimensional gels corresponding to two slightly acidic polypeptides differing in charge.
§ This polypeptide was not immunoprecipitated when it was labelled in vitro. The 12K polypeptides observed in vivo and in vitro may be distinct.
]1 Not applicable since this polypeptide was not identified during our studies.
protein. Only small amounts of the PVM N/39K and M proteins and the RS virus N protein were detected in immunoprecipitates prepared using the preimmune mouse serum. These were the most strongly labelled polypeptides in lysates of infected cells and since many cellular polypeptides were also detectable in these immunoprecipitates none of the polypeptides detected were considered to be specifically immunoprecipitated. It is possible that the mice possessed a low level of anti-PVM antibody before immunization. Neither anti-PVM nor anti-RS virus sera immunoprecipitated TRT virus polypeptides and anti-TRT virus sera did not immunoprecipitate PVM or RS virus polypeptides (Ling & Pringle, 1988) .
Specificity of anti-PVM MAbs
Seven hybridoma cell lines produced antibodies giving positive results in ELISA and immunofluorescence tests with PVM-infected but not with mock-infected BS-C-1 cells. The specificity of three of these antibodies could be determined by radioimmunoprecipitation and in one instance also by Western blotting. Fig. 4 shows immunoprecipitation of [35S]methioninelabelled PVM, RS virus and mock-infected cell lysates and culture supernatants concentrated by PEG precipitation. Antibody 19/1/C9 was not tested against RS virus samples (Fig. 4a ) but was negative in immunofluorescence tests with acetone-fixed RS virus-infected cells. Although this antibody regularly precipitated G1 and G2 polypeptides, other polypeptides were only sometimes precipitated suggesting that the GI and G2 polypeptides are related; this relationship has now been confirmed (Ling & Pringle, 1989) Antibody 26/1/Ell specifically precipitated the PVM M protein (Fig. 4b) . The PVM 39K polypeptide and also the N and P proteins of RS virus were precipitated by M A b 26/4/C4 (Fig.  4c) . Small amounts of the PVM L and 35K polypeptides and the RS virus L polypeptides were also precipitated. The specificity of this antibody is considered below. Although the N polypeptide has a mobility similar to that of the 39K polypeptide, comparison of chymotryptic digests of the N and 39K polypeptides with that of the polypeptide immunoprecipitated by M A b 26/4/C4 revealed that only the 39K polypeptide was recognized (see Fig. 8 ). Fig. 4 (d) shows a typical result obtained with a M A b that did not precipitate any polypeptides.
Antibody 26/l/A2 reacted with either the N or 39K polypeptides in Western blots but did not immunoprecipitate any polypeptides (data not shown). 
Cross-reaction of an anti-PVM MAb with the RS virus P protein
Further evidence for antigenic similarity between PVM and RS virus was obtained from the cross-reaction of M A b 26/4/C4 raised against PVM with an RS virus polypeptide. This crossreaction was initially identified in immunofluorescence tests. The reaction of M A b 26/4/C4 with PVM and RS virus polypeptides on Western blots is shown in Fig. 5 . It can be seen that the antibody bound to the PVM 39K polypeptide present in cell lysates and in P E G precipitates of the culture supernatant and also the RS virus P protein present in cell lysates. This antibody also bound to the RS virus P protein in P E G precipitates of the culture supernatant but the band was too faint to photograph. It did not bind to any polypeptide present in mock-infected cell lysates. proteins). Lambert et al. (1988) also identified several phosphorylated RS virus proteins which included the P and M proteins. PVM and TRT virus each had at least two phosphorylated polypeptides. The two phosphoproteins of PVM could not be unequivocally identified since each of them migrated in close proximity to another polypeptide. The lower mobility phosphoprotein was either the N or the 39K polypeptide and the higher mobility phosphoprotein was either the 20K or the 19K polypeptide. TRT virus had a phosphoprotein with an Mr of 35K and two phosphoproteins with Mrs of about 19K which could not always be resolved. A 43K phosphorylated protein was probably not virus-specific since a similar polypeptide was precipitated from uninfected cells by pooled anti-pneumovirus sera.
Phosphorylated polypeptides of P VM
Glycoproteins of PVM
Glycosylated polypeptides of PVM were identified by immunoprecipitation of [3H]glucosamine-labelled infected cell lysates and P E G precipitates of cell supernatants (Fig. 7) , In addition to the G1 and G2 polypeptides called II and III by Cash et al. (1979a) two poorly labelled polypeptides, F1 and 42K, were identified. The other bands in the PVM tracks were either not reproducible or were observed in immunoprecipitates from mock-infected cells using anti-PVM serum. The 42K polypeptide was immunoprecipitated by M A b 19/1/C9 (data not shown) and was therefore probably related to the G1/G2 polypeptide. No F2-1ike PVM polypeptide was identified although the RS virus F2 polypeptide was readily identified (apparently resolved into two bands in the P E G precipitate) along with the G and F1 proteins and a 22K protein (Fig. 7a) . Prolonged exposure of [3H]glucosamine-labelled PVM polypeptides enabled a diffuse smear of label centred around a mobility corresponding to an Mr of 31K to be observed (Fig. 7b) . 
IP
Pulse-chase analysis of P VM polypeptide processing
A pulse-chase experiment was carried out to study the possible processing of PVM polypeptides, the result being shown in Fig. 8 . A small amount of label incorporation appeared to have taken place up to 60 min of the chase period. This was insufficient to account for the appearance of the 12K polypeptide, however, suggesting that this polypeptide had a precursor. The precursor could not be identified. The processing of the G 1/G2 polypeptide is considered in the accompanying paper (Ling & Pringle, 1989) . A 17K polypeptide was detected only after the pulse label.
The M, 19K and 12K polypeptides became more abundant in the supernatant with increasing chase periods. The 20K polypeptide and the minor 23K, 17K and 16K polypeptides could not be identified in the supernatant on this gel. A coprecipitating host cell polypeptide prevented the identification of F1 in the supernatant samples. N and/or the 39K polypeptide appeared to be readily detected in the supernatant immediately following the chase period.
Possible relationships between P VM polypeptides
The results of partial digestion of PVM polypeptides with chymotrypsin are shown in Fig. 9 . These results show that the closely migrating N and 39K polypeptides were distinct but that the 39K and 35K polypeptides may have been related. In addition, minor 25K and 24K polypeptides synthesized in vitro may share peptides with the 39K and M polypeptides but since these were run on separate gels this was not clear (data not shown). The 20K and 19K polypeptides also share similar peptide patterns. 
DISCUSSION
A summary of the PVM-specific polypeptides that have been identified by us is given in Table  1 . The number of polypeptides indicated is greater than that of other paramyxoviruses including RS virus. This suggests that some of them may be related to each other; these are grouped together in the table. The 35K and 18K polypeptides were not identified in PEG precipitates as was found by Cash et al. (1979a) and so may be non-structural. Cash et al. (1979) identified an additional non-structural polypeptide that may correspond to the 12K polypeptide synthesized in vitro which is different from that identified in vivo since it was not recognized by the anti-PVM serum (data not shown). The finding that the 12K polypeptide identified in vivo was not a primary gene product also suggests that the 12K polypeptide identified in vivo and in vitro may be different.
The glycoproteins are considered in more detail in the accompanying paper (Ling & Pringle, 1989) , but there are probably no more than three (the G1/G2, F0/F1 and 31K proteins). A minor 42K glycoprotein appeared to be related to G 1/G2. RS virus has an attachment protein (G) and an F0 glycoprotein which is cleaved to give two disulphide-bonded polypeptides, F1 and F2. The smaller of the PVM glycoproteins producing a discrete band was designated F1 by analogy with the F1 glycoproteins of other paramyxoviruses (which have a similar mobility). No PVM polypeptide equivalent to the cleavage fragment F2 of other paramyxoviruses has been observed. The nature of the F-related proteins is considered further in the accompanying paper (Ling & Pringle, 1989) . A 48K polypeptide synthesized in vitro has a mobility more similar to that of F 1 than to any other polypeptide. Since the only polypeptides not identified in vitro were the F-and G-related polypeptides and the former appeared to be labelled with [35S]methionine more readily than G 1/G2, the 48K polypeptide was considered to be related to F 1. The nature of the 31K [3H]glucosamine-labelled polypeptide is not known. It was very diffuse and no labelled polypeptide could be related to it. It is not clear therefore whether it is a unique polypeptide or even a polypeptide at all. A similar smear of label has been observed with TRT virus (Ling & Pringle, 1988) and in immunoprecipitates of RS virus-infected cells obtained with an antiserum raised against a synthetic peptide corresponding to the carboxy terminus of the 1A protein (supplied by R. A. Olmsted and P. L. Collins) .
The N protein profile on two-dimensional gels was like that of the N protein of RS virus and it has been shown to be the major nucleocapsid polypeptide of PVM by Cash et al. (1979a) . The 39K and 35K polypeptides appeared to be related. Both polypeptides were synthesized in vitro (Cash et al., 1979a; Ling & Pringle, 1988) and no precursor-product relationship has been observed between them. Either they were synthesized independently or one of them was an artefact arising during sample preparation. The 39K protein may be analogous to the RS virus P protein since MAb 26/4/C4 binds to both of these proteins. The 39K polypeptide may be phosphorylated. The appearance of the N and/or 39K polypeptide in the supernatant immediately following the pulse period is difficult to explain. A possible explanation is that the cells were partially disrupted and the N and/or 39K polypeptide was released in a soluble form whereas the remaining polypeptides remained associated with membrane fragments or the cytoskeleton.
The polypeptides with estimated Mr values of less than 26K are probably not all primary gene products. The 25K and 24K proteins may be related to the 39K and M proteins, respectively. The 20K and 19K polypeptides also appeared to be related and the 12K polypeptide did not appear to be a primary gene product. This reduces the number of unique PVM polypeptides to ll or 12, i.e. the L, G, F, N, 39K/35K, M, 23K, 20K/19K, 18K, 17K, 16K and possibly 12K polypeptides. The exact number of polypeptides awaits molecular characterization of the PVM genome. Our results reveal antigenic similarities between the N proteins of PVM and RS virus and the 39K and P proteins of PVM and RS virus. The phosphoproteins of PVM had mobilities that were more similar to those of TRT virus than to those of RS virus. An F-like protein has been described for the first time in PVM.
